Source : Global Vaccine Market
The demand by countries for local production of vaccines is increasing. As a result such bioproducts tend to lead the way in terms of adopting of modern bioprocessing technology and services in less developed economies. In this context, the potential of emerging economies as major players on the global vaccine market is being recognised. Historically, the global vaccine manufacturing space was dominated by the "triad" - Japan, USA and European Union. In contrast, the emerging and less-developed markets have been, at least initially, focussed on local generics businesses. This was due to a number of factors, one being a lack of a congruent legislative framework for intellectual property protection.
No comments:
Post a Comment